Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-06 Sale |
2022-12-09 7:38 pm |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer |
440 | $4.9215 | $2,165 | 4,760 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-07 Option Award |
2024-06-07 7:25 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director |
5,051 | $0 | 9,740 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:11 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer |
1,734 | $0 | 4,760 (Direct) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:15 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
260,000 | $0 | 260,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
260,000 | $0 | 260,000 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-15 5:20 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Chief Business Officer |
920,000 | $0 | 920,000 (Direct) |
View |